Free Trial

Fresenius Medical Care AG & Co. KGaA (FMS) Stock Price, News & Analysis

Fresenius Medical Care AG & Co. KGaA logo
$23.18 +1.45 (+6.65%)
Closing price 11/4/2026 03:59 PM Eastern
Extended Trading
$23.42 +0.24 (+1.04%)
As of 08:48 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Fresenius Medical Care AG & Co. KGaA Stock (NYSE:FMS)

Advanced

Key Stats

Today's Range
$22.62
▼
$23.24
50-Day Range
$20.69
▼
$23.45
52-Week Range
$20.02
▼
$26.42
Volume
2.31 million shs
Average Volume
1.43 million shs
Market Capitalization
$12.33 billion
P/E Ratio
13.40
Dividend Yield
2.59%
Price Target
$23.43
Consensus Rating
Reduce

Company Overview

Fresenius Medical Care AG & Co. KGaA is a Germany-based health care company focused on the treatment of chronic kidney failure. The company provides dialysis care for patients with end-stage renal disease through a network of outpatient dialysis clinics and other health care facilities.

In addition to operating dialysis centers, Fresenius Medical Care develops and supplies products used in dialysis treatment. Its portfolio includes hemodialysis machines, dialyzers, dialysis solutions, bloodlines, and related medical devices and services. The company also provides clinical care, care coordination, and other services intended to support patients with chronic kidney disease.

Headquartered in Bad Homburg, Germany, Fresenius Medical Care serves patients and health care providers across multiple international markets, with a substantial presence in North America and Europe as well as operations in other regions. The company was established in 1996 through the combination of Fresenius Worldwide Dialysis and National Medical Care.

AI Generated. May Contain Errors.

Fresenius Medical Care AG & Co. KGaA Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
57th Percentile Overall Score

FMS MarketRank™: 
2.835911230665 of 5 stars

Fresenius Medical Care AG & Co. KGaA scored higher than 57% of companies evaluated by MarketBeat, and ranked 346th out of 891 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Fresenius Medical Care AG & Co. KGaA has received a consensus rating of Reduce. The company's average rating score is 1.64, and is based on no strong buy ratings, no buy ratings, 7 hold ratings, and 4 sell ratings.

  • Upside/Downside

    The consensus price target for Fresenius Medical Care AG & Co. KGaA is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    Fresenius Medical Care AG & Co. KGaA has only been the subject of 4 research reports in the past 90 days.

  • Read more about Fresenius Medical Care AG & Co. KGaA's stock forecast and price target.
  • Earnings Growth

    Earnings for Fresenius Medical Care AG & Co. KGaA are expected to grow by 5.36% in the coming year, from $2.24 to $2.36 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Fresenius Medical Care AG & Co. KGaA is 13.40, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.45.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Fresenius Medical Care AG & Co. KGaA is 13.40, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 36.25.

  • Price to Earnings Growth Ratio

    Fresenius Medical Care AG & Co. KGaA has a PEG Ratio of 5.07. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Fresenius Medical Care AG & Co. KGaA has a P/B Ratio of 0.80. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.74% of the float of Fresenius Medical Care AG & Co. KGaA has been sold short.
  • Short Interest Ratio / Days to Cover

    Fresenius Medical Care AG & Co. KGaA has a short interest ratio ("days to cover") of 3.51, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Fresenius Medical Care AG & Co. KGaA has recently increased by 39.71%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Fresenius Medical Care AG & Co. KGaA pays a meaningful dividend of 2.68%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Fresenius Medical Care AG & Co. KGaA does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Fresenius Medical Care AG & Co. KGaA is 34.68%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Fresenius Medical Care AG & Co. KGaA will have a dividend payout ratio of 25.42% next year. This indicates that Fresenius Medical Care AG & Co. KGaA will be able to sustain or increase its dividend.

  • Read more about Fresenius Medical Care AG & Co. KGaA's dividend.
  • News Sentiment

    Fresenius Medical Care AG & Co. KGaA has a news sentiment score of 0.53. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.40 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 9 news articles for Fresenius Medical Care AG & Co. KGaA this week, compared to 1 article on an average week.
  • Search Interest

    Only 1 people have searched for FMS on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
Receive FMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius Medical Care AG & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

FMS Stock News Headlines

Fresenius Medical Care AG & Co. KGaA Q3 2026 Earnings Call Summary
Fresenius Medical Care AG (FMS) Q3 2026 Earnings Call Transcript
I'm handing you this one free
Elon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds, he licenses it from one overlooked company. That supplier just got a major catalyst. Musk filed to launch 1,000,000 satellites, a move analyst Dylan believes could drive a 100X bigger bill for this chipmaker starting December 8th.tc pixel
Fresenius Medical cuts top end of 2026 profit outlook
See More Headlines

FMS Stock Analysis - Frequently Asked Questions

Fresenius Medical Care AG & Co. KGaA's stock was trading at $23.84 at the start of the year. Since then, FMS stock has decreased by 2.8% and is now trading at $23.1750.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) released its quarterly earnings results on Monday, August, 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.62 by $0.04. The company had revenue of $5.55 billion for the quarter, compared to analysts' expectations of $5.48 billion. Fresenius Medical Care AG & Co. KGaA had a net margin of 4.23% and a trailing twelve-month return on equity of 9.03%.
Read the conference call transcript
.

Fresenius Medical Care AG & Co. KGaA subsidiaries include NxStage Medical.

Fresenius Medical Care AG & Co. KGaA's top institutional investors include Pzena Investment Management LLC (3.09%), Crossmark Global Holdings Inc. (0.01%), Quadrant Capital Group LLC (0.01%) and DMC Group LLC.

Shares of FMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Fresenius Medical Care AG & Co. KGaA investors own include JPMorgan Chase & Co. (JPM), AT&T (T), Energy Transfer (ET), Coca-Cola (KO), Fresenius Medical Care (FME), Cisco Systems (CSCO) and Alphabet (GOOG).

Company Calendar

Last Earnings
8/03/2026
Today
11/05/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Services
Current Symbol
NYSE:FMS
CIK
1333141
Employees
1,488
Year Founded
1912

Price Target and Rating

High Price Target
$25.80
Low Price Target
$19.90
Potential Upside/Downside
+1.1%
Consensus Rating
Reduce
Rating Score (0-4)
1.64
Research Coverage
11 Analysts

Profitability

EPS (Trailing Twelve Months)
$1.73
Trailing P/E Ratio
13.40
Forward P/E Ratio
9.82
P/E Growth
5.07
Net Income
$1.11 billion
Net Margins
4.23%
Pretax Margin
7.67%
Return on Equity
9.03%
Return on Assets
4.05%

Debt

Debt-to-Equity Ratio
0.43
Current Ratio
1.07
Quick Ratio
0.75

Sales & Book Value

Annual Sales
$19.48 billion
Price / Sales
0.63
Cash Flow
$5.94 per share
Price / Cash Flow
3.90
Book Value
$28.93 per share
Price / Book
0.80

Miscellaneous

Outstanding Shares
532,219,000
Free Float
N/A
Market Cap
$12.33 billion
Optionable
Optionable
Beta
0.78

Social Links

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

This page (NYSE:FMS) was last updated on 11/4/2026 by MarketBeat.com Staff.
From Our Partners